Trial · NCT04115319
Adverse events40
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 40
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Weight decreased | Investigations | SEP-363856 50 to 100 mg/Day | 11 | 201 | 11 |
| other | Weight decreased | Investigations | Quetiapine XR 400 to 800 mg/Day | 1 | 102 | 1 |
| other | Weight increased | Investigations | SEP-363856 50 to 100 mg/Day | 9 | 201 | 9 |
| other | Weight increased | Investigations | Quetiapine XR 400 to 800 mg/Day | 11 | 102 | 11 |
| other | Akathisia | Nervous system disorders | SEP-363856 50 to 100 mg/Day | 14 | 201 | 15 |
| other | Akathisia | Nervous system disorders | Quetiapine XR 400 to 800 mg/Day | 2 | 102 | 2 |
| other | Dizziness | Nervous system disorders | SEP-363856 50 to 100 mg/Day | 16 | 201 | 18 |
| other | Dizziness | Nervous system disorders | Quetiapine XR 400 to 800 mg/Day | 5 | 102 | 5 |
| other | Headache | Nervous system disorders | SEP-363856 50 to 100 mg/Day | 20 | 201 | 29 |
| other | Headache | Nervous system disorders | Quetiapine XR 400 to 800 mg/Day | 8 | 102 | 8 |
| other | Somnolence | Nervous system disorders | SEP-363856 50 to 100 mg/Day | 12 | 201 | 13 |
| other | Somnolence | Nervous system disorders | Quetiapine XR 400 to 800 mg/Day | 21 | 102 | 24 |
| other | Asthenia | General disorders | SEP-363856 50 to 100 mg/Day | 5 | 201 | 6 |
| other | Asthenia | General disorders | Quetiapine XR 400 to 800 mg/Day | 9 | 102 | 10 |
| other | Constipation | Gastrointestinal disorders | SEP-363856 50 to 100 mg/Day | 7 | 201 | 8 |
| other | Constipation | Gastrointestinal disorders | Quetiapine XR 400 to 800 mg/Day | 12 | 102 | 16 |
| other | Nausea | Gastrointestinal disorders | SEP-363856 50 to 100 mg/Day | 13 | 201 | 13 |
| other | Nausea | Gastrointestinal disorders | Quetiapine XR 400 to 800 mg/Day | 4 | 102 | 5 |
| other | Anxiety | Psychiatric disorders | SEP-363856 50 to 100 mg/Day | 27 | 201 | 41 |
| other | Anxiety | Psychiatric disorders | Quetiapine XR 400 to 800 mg/Day | 10 | 102 | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04115319/events